Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence
about
Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysisContraceptive methods and risk of HIV acquisition or female-to-male transmissionIntegrating prevention interventions for people living with HIV into care and treatment programs: a systematic review of the evidence.A Novel Microbicide/Contraceptive Intravaginal Ring Protects Macaque Genital Mucosa against SHIV-RT Infection Ex VivoHormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studiesOral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial.Friend or Foe: Innate Sensing of HIV in the Female Reproductive Tract.A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities.Broadening the debate over HIV and hormonal contraception.Contraception and prevention of HIV transmission: a potential conflict of public health principles.Sustained High HIV Incidence in Young Women in Southern Africa: Social, Behavioral, and Structural Factors and Emerging Intervention ApproachesHormonal contraception does not increase women's HIV acquisition risk in Zambian discordant couples, 1994-2012The levonorgestrel-releasing intrauterine system is associated with delayed endocervical clearance of Chlamydia trachomatis without alterations in vaginal microbiota.Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.Molecular Signatures of Immune Activation and Epithelial Barrier Remodeling Are Enhanced during the Luteal Phase of the Menstrual Cycle: Implications for HIV Susceptibility.Levels of Genital Tract Defensins and Cytokines Differ between HIV-Uninfected US and African Women.Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model.Prevalence of Herpes Simplex Virus 2 (HSV-2) infection and associated risk factors in a cohort of HIV negative women in Durban, South Africa.Brief Report: Hormonal Contraception Is Not Associated With Reduced ART Effectiveness Among Women Initiating ART: Evidence From Longitudinal Data.Temporal Trends and Predictors of Modern Contraceptive Use in Lusaka, Zambia, 2004-2011.Changes in Vaginal Microbiota and Immune Mediators in HIV-1-Seronegative Kenyan Women Initiating Depot Medroxyprogesterone Acetate.Comparison of Follicular and Luteal Phase Mucosal Markers of HIV Susceptibility in Healthy WomenAn updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women.Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study.Long-acting hormonal contraception.Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda.Assessing the Potential Impact of Hormonal-Based Contraceptives on HIV Transmission Dynamics Among Heterosexuals.Review on the Biological Mechanisms Associated with Depo-Provera and HIV-1 Risk Acquisition in Women.Current and future contraceptive options for women living with HIV.Objective Measurement of Inaccurate Condom Use Reporting Among Women Using Depot Medroxyprogesterone Acetate for Contraception.A Depot Medroxyprogesterone Acetate Dose That Models Human Use and Its Effect on Vaginal SHIV Acquisition Risk.Analysis of putative mucosal SHIV susceptibility factors during repeated DMPA treatments in pigtail macaques.Contraceptive Practice in Sub-Saharan Africa.Exogenous oestrogen inhibits genital transmission of cell-associated HIV-1 in DMPA-treated humanized mice.Uptake and correlates of contraception among postpartum women in Kenya: results from a national cross-sectional survey.From Research to Policy: The WHO Experience With Developing Guidelines on the Potential Risk of HIV Acquisition and Progestogen-Only Contraception Use.Concordance of self-reported hormonal contraceptive use and presence of exogenous hormones in serum among African women.
P2860
Q21144588-83D84796-F716-4766-8E8A-A99C675A6704Q27027323-73BF018D-C53A-4797-AA26-42051BE4D837Q27313271-EB80CE0E-FE1E-42F9-803E-6516B8E2E619Q27334384-1DE4D219-2F1A-4ACC-9F47-479F173F8B53Q30660068-D331CDFE-B22B-491B-AF40-28F63E66F424Q31014284-1EBB8722-2083-49B5-A61A-3DEFF1BCB511Q33613121-A056F0A8-A514-4085-9826-E4A3C3A6E9E3Q33763511-760E7B46-132D-41E2-AE27-DC3212B7BFFDQ34457619-1FCADB61-8D32-4353-8614-02E3E7BECE27Q34818925-7FC58646-EEDB-4EB0-806E-6DFF5E760734Q35602771-BA2C824D-C33C-4C11-9EEF-1C91FAF9DBD9Q35639676-BCF4641A-2738-4046-A5FA-BCBCC6085D17Q35775563-C7A721B0-424A-49C1-BB34-A50704FD896AQ35817142-3A521D46-F400-460D-A76F-66BDA75BC3F4Q35913894-CF6A28BF-86D1-46AE-B0D6-F810D5DE9D0BQ36068904-F5EA84EA-11B3-4E2D-9854-94F85A461DDAQ36080869-14A8A1C9-1081-41E3-89DF-5984DD9D54AFQ36220941-170432AE-EA87-4D80-8A10-85F1AD25A680Q36343568-409276BF-4240-4C75-8FDA-4A9FEE753E45Q36446880-FE66EAA5-2607-4A80-821A-6F4C06AAB1C0Q36629905-24E634A7-879E-4D61-BF41-AB8BB3916671Q36966645-833683AA-C381-4008-B4EC-4796B262F319Q37409664-81E3E971-9157-4706-91A7-0CB57F2B8CF7Q37628108-8A641D3C-FABF-4D78-A38B-2F9DC9D680A7Q38655482-886D9B09-41F7-41CB-A131-823B2090E671Q38858718-14C2E236-F096-4BA0-BEDD-501A84730F26Q38930251-0D711A1B-D84B-40DA-9656-A7B884EB5114Q39347553-ED929889-F0A0-405B-A0F9-1254E8E3429AQ40048203-71D7579C-4FB1-48BF-859E-0501430A84EEQ40517790-812D74A6-6724-4AB4-B71F-AC298BE6386FQ40632328-CFD7133F-206D-42B8-BFA8-A39C71555F87Q41074827-54D93C82-89E6-4E9A-8AC8-0632D5062FB4Q46663039-BD968D66-3598-4904-B32D-3D60975749FBQ47553314-99626724-5224-41FD-8DCB-DCBD674FBE78Q47795304-4228DD8E-833F-46ED-8327-32DF735220E6Q49365936-014028C4-57AA-4FCD-B092-3CB340FE2E41Q50142380-EFA9BFFF-3D14-4A0C-A78D-2AF134968350
P2860
Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Hormonal contraceptive methods ...... ew of epidemiological evidence
@ast
Hormonal contraceptive methods ...... ew of epidemiological evidence
@en
Hormonal contraceptive methods ...... ew of epidemiological evidence
@nl
type
label
Hormonal contraceptive methods ...... ew of epidemiological evidence
@ast
Hormonal contraceptive methods ...... ew of epidemiological evidence
@en
Hormonal contraceptive methods ...... ew of epidemiological evidence
@nl
prefLabel
Hormonal contraceptive methods ...... ew of epidemiological evidence
@ast
Hormonal contraceptive methods ...... ew of epidemiological evidence
@en
Hormonal contraceptive methods ...... ew of epidemiological evidence
@nl
P2093
P3181
P1433
P1476
Hormonal contraceptive methods ...... ew of epidemiological evidence
@en
P2093
Abigail Norris Turner
Daniel J Westreich
Elizabeth Raymond
Kathryn M Curtis
Petrus S Steyn
Philip Hannaford
P304
P3181
P356
10.1016/J.CONTRACEPTION.2014.07.009
P407
P577
2014-07-23T00:00:00Z